Cyrenaic Pharmaceuticals' Unattributed VC Round

Cyrenaic Pharmaceuticals raised a round of funding on January 01, 2007.

Cyrenaic is a drug development only company dedicated to the development of an innovative compound CYR 101 in the field of Schizophrenia which has been in licensed from Mitsubishi Pharma Corporation. …

Articles about Cyrenaic Pharmaceuticals' Unattributed VC Round: